A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol

被引:0
作者
Sergio Fragoso-Saavedra
David A. Iruegas-Nunez
Alejandro Quintero-Villegas
H. Benjamín García-González
Isaac Nuñez
Sergio L. Carbajal-Morelos
Belem M. Audelo-Cruz
Sarahi Arias-Martínez
Yanink Caro-Vega
Juan José Calva
Verónica Luqueño-Martínez
Alejandra González-Duarte
Brenda Crabtree-Ramírez
José C. Crispín
Juan Sierra-Madero
Pablo F. Belaunzarán-Zamudio
Sergio I. Valdés-Ferrer
机构
[1] Universidad Nacional Autónoma de Mexico,Programa de Estudios Combinados en Medicina (MD/PhD program)
[2] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,Departamento de Neurología
[3] Escuela Nacional de Medicina y Ciencias de la Salud,Internal Medicine Residency Training Program
[4] Instituto Tecnológico y de Destudios Superiores de Monterrey,Departamento de Infectología
[5] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,Departamento de e Inmunología y Reumatología
[6] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,Division of AIDS, National Institute of Allergy and Infectious Diseases
[7] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,Center for Biomedical Science
[8] National Institutes of Health,undefined
[9] Feinstein Institute for Medical Research,undefined
来源
BMC Infectious Diseases | / 20卷
关键词
COVID-19; SARS-Cov-2; Mortality; Invasive mechanical ventilation; Immunomodulation; Pyridostigmine; ACh; Inflammatory reflex; Placebo-controlled trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 112 条
  • [1] Huang C(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 497-506
  • [2] Wang Y(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet. 6736 1-9
  • [3] Li X(2020)Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Intensive Care Med 46 846-848
  • [4] Ren L(2020)COVID-19: consider cytokine storm syndromes and immunosuppression Lancet. 6736 19-20
  • [5] Zhao J(2014)The challenges of long-term sepsis survivors: when surviving is just the beginning Rev Investig Clin 66 439-1036
  • [6] Hu Y(2015)Myasthenia gravis: subgroup classification and therapeutic strategies Lancet Neurol 14 1023-695
  • [7] Zhou F(1991)Pyridostigmine used as a nerve agent pretreatment under wartime conditions JAMA J Am Med Assoc 266 693-559
  • [8] Yu T(2009)Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV AIDS Res Hum Retrovir 25 749-462
  • [9] Du R(2017)Add-on Pyridostigmine enhances CD4 Front Immunol 8 1301-27
  • [10] Fan G(2019)T-cell recovery in HIV-1-infected immunological non-responders: A proof-of-concept study J Neuro-Oncol 25 551-8289